Atossa Therapeutics
ATOS
#9174
Rank
NZ$0.19 B
Marketcap
NZ$1.49
Share price
6.58%
Change (1 day)
-30.23%
Change (1 year)

EPS for Atossa Therapeutics (ATOS)

EPS in 2025 (TTM): NZ-$0.38

According to Atossa Therapeutics's latest financial reports the company's current EPS (TTM) is NZ-$0.40. In 2024 the company made an earnings per share (EPS) of NZ-$0.35 an increase over its 2023 EPS that were of NZ-$0.41.

EPS history for Atossa Therapeutics from 2010 to 2025

Annual EPS

Year EPS Change
2025 (TTM)NZ-$0.389.9%
2024NZ-$0.35-16.67%
2023NZ-$0.4114.29%
2022NZ-$0.3616.67%
2021NZ-$0.31-90.86%
2020NZ-$3.40-2.96%
2019NZ-$3.51-63.09%
2018NZ-$9.50-49.63%
2017NZ-$18.86-57.87%
2016NZ-$44.76-74.01%
2015NZ-$172.22-9.18%
2014NZ-$189.62-12.86%
2013NZ-$217.6070.73%
2012NZ-$127.4534.08%
2011NZ-$95.06263.47%
2010NZ-$26.15

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
NZ$18.03-4,638.87%๐Ÿ‡บ๐Ÿ‡ธ USA
LabCorp
LH
NZ$17.70-4,556.52%๐Ÿ‡บ๐Ÿ‡ธ USA
Quest Diagnostics
DGX
NZ$14.92-3,856.52%๐Ÿ‡บ๐Ÿ‡ธ USA
Enzo Biochem
ENZB
NZ-$0.36-8.70%๐Ÿ‡บ๐Ÿ‡ธ USA
NeoGenomics
NEO
NZ-$1.52 282.61%๐Ÿ‡บ๐Ÿ‡ธ USA